Cargando…

Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer

Lung cancer is the most commonly occurring type of cancer worldwide and also has the highest mortality rate. Although targeted therapy of non-small cell lung carcinoma (NSCLC) has become common, the majority of patients receiving first-line epithelial growth factor receptor (EGFR)-TKI treatment deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ruilian, Zhong, Guolin, Huang, Tanxiao, He, Wan, Kong, Cheng, Zhang, Xiaoni, Wang, Ying, Liu, Ming, Xu, Mingyan, Chen, Shifu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843997/ https://www.ncbi.nlm.nih.gov/pubmed/29556275 http://dx.doi.org/10.3892/ol.2018.7808

Ejemplares similares

Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
por: Sun, Xiao, et al.
Publicado: (2018)

Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy
por: Cao, Hua, et al.
Publicado: (2020)

GeneFuse: detection and visualization of target gene fusions from DNA sequencing data
por: Chen, Shifu, et al.
Publicado: (2018)

MutScan: fast detection and visualization of target mutations by scanning FASTQ data
por: Chen, Shifu, et al.
Publicado: (2018)

Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer
por: He, Wan, et al.
Publicado: (2022)

AfterQC: automatic filtering, trimming, error removing and quality control for fastq data
por: Chen, Shifu, et al.
Publicado: (2017)

ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC
por: Chen, Yao, et al.
Publicado: (2020)

Identification of a novel germline frameshift mutation p.D300fs of PMS1 in a patient with hepatocellular carcinoma: A case report and literature review
por: Li, Xiaobin, et al.
Publicado: (2020)

Efficient sequencing data compression and FPGA acceleration based on a two-step framework
por: Chen, Shifu, et al.
Publicado: (2023)

Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease
por: Wei, Zhangjing, et al.
Publicado: (2016)

The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
por: Wu, Guowu, et al.
Publicado: (2022)

Evaluation of Pembrolizumab Monotherapy Efficacy in Advanced Non-Small-Cell Lung Cancer by Serial Monitoring of Circulating Tumor DNA Using Next-Generation Sequencing
por: Wang, Buhai, et al.
Publicado: (2022)

Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data
por: Chen, Shifu, et al.
Publicado: (2019)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Circulating Methylated DNA to Monitor the Dynamics of RAS Mutation Clearance in Plasma from Metastatic Colorectal Cancer Patients
por: Nicolazzo, Chiara, et al.
Publicado: (2020)

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
por: Stensgaard, Simone, et al.
Publicado: (2023)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
por: Mayer, Stefanie, et al.
Publicado: (2020)

Application of circulating tumor DNA for dynamic monitoring of advanced non‐small cell lung cancer treatment response: An open‐label, multicenter, prospective, observational study protocol
por: Gao, Zhenlin, et al.
Publicado: (2019)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression
por: Fu, Yun, et al.
Publicado: (2021)

Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
por: Chang, Yi, et al.
Publicado: (2017)

Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA
por: Willey, James C., et al.
Publicado: (2021)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
por: Yi, Zongbi, et al.
Publicado: (2017)

Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial Sarcomas
por: Eisenhardt, Anja E., et al.
Publicado: (2022)

Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients
por: Ryu, Woo Kyung, et al.
Publicado: (2022)

Genomic temporal heterogeneity of circulating tumour DNA in unresectable metastatic colorectal cancer under first-line treatment
por: Wang, Feng, et al.
Publicado: (2022)

Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
por: Sugimori, Makoto, et al.
Publicado: (2019)

Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer
por: Hofste, Lisa S. M., et al.
Publicado: (2022)

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases
por: Wang, De-Shen, et al.
Publicado: (2021)

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer
por: Li, Yilin, et al.
Publicado: (2016)

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022)

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma
por: Liu, Xiang-Liang, et al.
Publicado: (2021)

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma
por: Fontanilles, Maxime, et al.
Publicado: (2020)

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
por: Fujii, Yasutoshi, et al.
Publicado: (2021)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
por: Sclafani, Francesco, et al.
Publicado: (2018)

Personalized circulating tumor DNA detection to monitor immunotherapy efficacy and predict outcome in locally advanced or metastatic non‐small cell lung cancer
por: Cheng, Lei, et al.
Publicado: (2023)

OPRM1-ROS1 Fusion Detected by Next-Generation Sequencing with Circulating DNA in a Patient with EGFR Mutated Advanced NSCLC: A Case Report
por: Zhang, Sicai, et al.
Publicado: (2022)

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer
por: Yao, Yu, et al.
Publicado: (2016)

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
por: Liao, Wenjun, et al.
Publicado: (2016)

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer
por: He, Yayi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b7eifnf4v32v8aof03p8a4ijbk